Table 2.
Temporal trends in ART expansion and patient characteristics from 2006 to 2014. Values are numbers (%) or median (IQR)
| 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | Total | |
|---|---|---|---|---|---|---|---|---|---|---|
| ART initiations | 1488 | 1655 | 2354 | 2951 | 3536 | 3369 | 3039 | 3188 | 3192 | 24 772 |
| Men | 539 (36) | 580 (35) | 827 (35) | 1012 (34) | 1228 (35) | 1187 (35) | 1112 (37) | 1020 (32) | 988 (31) | 8493 (34) |
| Non‐pregnant women | 248 (17) | 462 (28) | 880 (37) | 1625 (55) | 1959 (55) | 1781 (53) | 1557 (51) | 1729 (54) | 1746 (55) | 11 987 (48) |
| Pregnant women | 3 (0) | 30 (2) | 86 (4) | 119 (4) | 172 (5) | 245 (7) | 268 (9) | 337 (11) | 383 (12) | 1643 (7) |
| Missinga | 698 (47) | 583 (35) | 561 (24) | 195 (7) | 177 (5) | 156 (5) | 102 (3) | 102 (3) | 75 (2) | 2649 (11) |
| Age, years (missing n = 0) | 35 (28–43.5) | 34 (29–43) | 34 (28–43) | 35 (28–45) | 34 (27–43) | 33 (27–42) | 33 (27–42) | 32 (26–41) | 31 (25–39) | 33 (27–42) |
| 16–24 | 166 (11) | 181 (11) | 302 (13) | 378 (13) | 504 (14) | 475 (14) | 451 (15) | 616 (19) | 686 (21) | 3759 (15) |
| 25–34 | 543 (36) | 665 (40) | 876 (37) | 1071 (36) | 1379 (39) | 1406 (42) | 1261 (41) | 1306 (41) | 1360 (43) | 9867 (40) |
| 35–44 | 439 (30) | 459 (28) | 645 (27) | 762 (26) | 879 (25) | 805 (24) | 712 (23) | 689 (22) | 654 (20) | 6044 (24) |
| 45–54 | 234 (16) | 212 (13) | 346 (15) | 449 (15) | 476 (13) | 437 (13) | 382 (13) | 364 (11) | 291 (9) | 3191 (13) |
| ≥55 | 106 (7) | 138 (8) | 185 (8) | 291 (10) | 298 (8) | 246 (7) | 233 (8) | 213 (7) | 201 (6) | 1911 (8) |
| CD4 count, cells/mm3 (missing n = 36) | 113 (55–174) | 127 (59–191) | 140 (70–213) | 157 (79–236) | 194 (98–289) | 198 (103–294) | 203 (100.5–295) | 243 (125–336) | 265 (136–368) | 183 (91‐287) |
| Men | 99 (42–157) | 102.5 (46–179) | 117 (53–187) | 127 (58–208) | 156 (73–256) | 164.5 (79–267.5) | 159 (69–259) | 182 (96–289) | 188 (87–297) | 145 (68‐245) |
| Non‐pregnant women | 132.5 (71.5–185) | 144.5 (66–200) | 143 (76–213) | 168 (92–246) | 205 (107–297) | 209 (117–299) | 220 (118.5–304) | 259 (143–345) | 287 (166–403) | 205 (108‐303) |
| Pregnant women | 78 (58–94) | 211.5 (146–291) | 225 (146–306) | 231 (153–279) | 237.5 (156.5–308.5) | 252 (176–319) | 264 (174–316) | 304 (220–432) | 343.5 (230–499) | 272 (186–346) |
| 0–100 | 651 (44) | 677 (41) | 824 (35) | 917 (31) | 911 (26) | 820 (24) | 759 (25) | 642 (20) | 616 (19) | 6817 (28) |
| 101–200 | 617 (42) | 616 (37) | 868 (37) | 976 (33) | 929 (26) | 890 (26) | 739 (24) | 638 (20) | 570 (18) | 6843 (28) |
| 201–350 | 170 (11) | 292 (18) | 576 (25) | 929 (32) | 1310 (37) | 1300 (39) | 1234 (41) | 1224 (38) | 1110 (35) | 8145 (33) |
| 351–500 | 32 (2) | 45 (3) | 66 (3) | 91 (3) | 268 (8) | 249 (7) | 226 (7) | 412 (13) | 473 (15) | 1862 (8) |
| ≥501 | 16 (1) | 23 (1) | 17 (1) | 33 (1) | 116 (3) | 106 (3) | 78 (3) | 268 (8) | 412 (13) | 1069 (4) |
| WHO staging (missing n = 13) | ||||||||||
| I+II | 615 (41) | 718 (43) | 1027 (44) | 1462 (50) | 1927 (55) | 2030 (60) | 1989 (65) | 2448 (77) | 2561 (80) | 14 777 (60) |
| III | 676 (45) | 754 (46) | 1077 (46) | 1230 (42) | 1407 (40) | 1159 (34) | 907 (30) | 637 (20) | 542 (17) | 8389 (34) |
| IV | 196 (13) | 183 (11) | 249 (11) | 258 (9) | 200 (6) | 177 (5) | 141 (5) | 101 (3) | 88 (3) | 1593 (6) |
| NRTI (missing n = 0) | ||||||||||
| ABC | 3 (0) | 2 (0) | 3 (0) | 39 (1) | 20 (1) | 15 (0) | 33 (1) | 27 (1) | 28 (1) | 170 (1) |
| AZT | 275 (18) | 917 (55) | 1664 (71) | 2503 (85) | 2292 (65) | 659 (20) | 564 (19) | 352 (11) | 330 (10) | 9556 (39) |
| D4T | 1192 (80) | 720 (44) | 664 (28) | 349 (12) | 181 (5) | 25 (1) | 20 (1) | 7 (0) | 9 (0) | 3167 (13) |
| TDF | 18 (1) | 16 (1) | 23 (1) | 60 (2) | 1043 (29) | 2670 (79) | 2422 (80) | 2802 (88) | 2825 (89) | 11 879 (48) |
| NNRTI (missing n = 0) | ||||||||||
| EFV | 475 (32) | 465 (28) | 506 (21) | 824 (28) | 1411 (40) | 2771 (82) | 2456 (81) | 2832 (89) | 2892 (91) | 14 632 (59) |
| NVP | 1013 (68) | 1190 (72) | 1848 (79) | 2127 (72) | 2125 (60) | 598 (18) | 583 (19) | 356 (11) | 300 (9) | 10 140 (41) |
n, number; IQR, interquartile range; WHO, World Health Organization; NRTI, nucleoside reverse transcriptase inhibitor; AZT, zidovudine; ABC, abacavir; D4T, stavudine; TDF, tenofovir disoproxil fumarate; NNRTI, non‐nucleoside reverse transcriptase inhibitors; EFV, efavirenz; NVP, nevirapine.
a
The greatest proportion of missing values was for pregnancy status (11%), while only <1% had missing sex status.